New Filings & Updated Terms (Week ending 07.02.20pm) (FREE)

NEW FILINGS

Company: Nurix Therapeutics, Inc.
Symbol: NRIX
Description: They are a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): JP Morgan, Piper Sandler, Stifel
Co-Manager: Needham
Filed: 7-2-20
Listed Cash Raise: $100m

Company: Inozyme Pharma, Inc.
Symbol: INZY
Description: They are a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): BofA Securities, Cowen, Piper Sandler
Co-Manager: Wedbush PacGrow
Filed: 7-2-20
Listed Cash Raise: $86.25m

Company: Annexon, Inc.
Symbol: ANNX
Description: They are a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): JP Morgan, BofA Securities, Cowen
Filed: 7-2-20
Listed Cash Raise: $100m

Company: Vertex, Inc.
Symbol: VERX
Description: Vertex delivers comprehensive tax solutions that enable global businesses to transact, comply and grow with confidence.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, Morgan Stanley, BofA Securities, Citigroup, Jefferies
Co-Manager: JMP Securities, Stifel, William Blair, CastleOak Securities, L.P.
Filed: 07-02-20
Listed Cash Raise: $100m

Company: Montrose Environmental Group, Inc.
Symbol: MEG
Description: They service complex, recurring and often non-discretionary environmental needs of our diverse clients across our three business segments: Assessment, Permitting and Response; Measurement and Analysis; and Remediation and Reuse.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): BofA Securities, William Blair
Co-Manager:BNP PARIBAS, Capital One Securities, Stifel, Needham & Company
Filed: 6-30-20
Listed Cash Raise: $160m

Company: Jamf Holding Corp.
Symbol: TBD
Description: They are the standard in Apple Enterprise Management, and our cloud software platform is the only vertically-focused Apple infrastructure and security platform of scale in the world.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, J.P. Morgan, BofA Securities, Barclays, RBC Capital Markets, Mizuho Securities, HSBC
Co-Manager: Canaccord Genuity, JMP Securities, Piper Sandler, William Blair, Loop Capital Markets, CastleOak Securities, L.P.
Filed: 6-30-20
Listed Cash Raise: $100m

Company: ALX Oncology Holdings Inc.
Symbol: ALXO
Description: They are a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): Jefferies, Credit Suisse, Piper Sandler, Cantor
Co-Manager: Life Sciences Advisors
Filed: 6-26-20
Listed Cash Raise: $100m

Company: Pandion Therapeutics, Inc.
Symbol: PAND
Description: They are a clinical stage biopharmaceutical company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, Morgan Stanley, SVB Leerink, BMO Capital Markets
Filed: 6-26-20
Listed Cash Raise: $75m

Company: Berkeley Lights, Inc.
Symbol: BLI
Description: Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): JP Morgan, Morgan Stanley, Cowen
Co-Manager: William Blair
Filed: 6-26-20
Listed Cash Raise: $100m

Company: ACell Inc.
Symbol: ACLL
Description: They are a leading regenerative medicine company focused on the development, manufacture and sale of products primarily used in acute care settings as part of the treatment and management of moderate to severe wounds and reinforcement of soft tissue surgical defects.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriter(s): UBS Investment Bank, Barclays, RBC Capital Markets
Co-Manager: SunTrust Robinson Humphrey
Filed: 6-26-20
Listed Cash Raise: $86.

TERMS ADDED

Company: Quhuo Limited
Symbol: QH
Description: They were the largest workforce operational solution platform in China as measured by the number of average monthly active workers in 2019, according to the F&S report. They provide tech-enabled, end-to-end operational solutions to blue-chip on-demand consumer service businesses in industries with significant e-commerce exposure, including food delivery, ride-hailing, housekeeping and bike-sharing.
Shares: 2.7 million ADSs
Price Range: $9.00-$11.00
Market Cap: $461m-$564m
Trade Date: Week of July 6
Underwriter(s): Roth Capital Partners, Valuable Capital Limited, Tiger Brokers
Terms Added: 6-30-20

Company: BlueCity Holdings Limited
Symbol: BLCT
Description: They are the World’s leading LGBTQ platform.
Shares: 5.3 million ADSs
Price Range: $15.00-$17.00
Market Cap: $534m-$605m
Trade Date: Wednesday, July 8
Underwriter(s):AMTD, Loop Capital Markets, Tiger Brokers, Prime Number Capital, R.F. Lafferty
Terms Added: 7-1-20

Company: Nkarta, Inc.
Symbol: NKTX
Description: They are a biopharmaceutical company focused on the discovery, development and commercialization of allogeneic, off-the-shelf engineered natural killer, or NK, cell therapies to treat cancer.
Shares: 10 million
Price Range: $14.00-$16.00
Market Cap: $370m-$423m
Trade Date: Friday, 7/10
Underwriter(s): Cowen, Evercore, Stifel, Mizuho
Terms Added: 7-2-20